Skip to content

Depression: all studies

Page 253 of 1,040: studies 2,521 to 2,530 of 10,391, newest first. Back to the depression overview

Research

The Effect of Mindfulness-Based Training on Stress, Anxiety, Depression, and Job Satisfaction Among Ward Nurses: A Randomized Control Trial.

Journal of Nursing Management May 20, 2020 Sajed Faisal Ghawadra, Khatijah Lim Abdullah, W. Choo et al.

AIM To assess the effect of a 4-week Mindfulness-Based Training intervention on improving stress, anxiety, depression, and job satisfaction among ward nurses. BACKGROUND Previous literature showed that mindfulness training is useful for helping nurses cope with stress. METHOD Nurses who have mild to moderate levels of stress, anxiety, and depression identified from a teaching hospital were...

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent

The Journal of Clinical Psychiatry May 11, 2020 Dong-Jing Fu, Dawn F. Ionescu, Xiang Li et al. 367 citations

OBJECTIVE: To compare esketamine to placebo, each in addition to standard-of-care treatment, for rapidly reducing major depressive disorder symptoms, including suicidal ideation. METHODS: This phase 3, double-blind, multicenter study (ASPIRE I), conducted between June 2017 and December 2018, enrolled 226 adults having major depressive disorder based on Diagnostic and Statistical Manual of...

Effectiveness of mindfulness-based cognitive therapy on the management of depressive disorder: Systematic review

International Journal of Africa Nursing Sciences May 1, 2020 Zulkiflu Argungu Musa, Soh Kim Lam, Firdaus Binti Mamat @ Mukhtar et al.

Mindfulness-Based Cognitive Therapy (MBCT) was developed to prevent relapse in people with depressive disorders, and it help individuals better understand and manage their thoughts and emotions in order to achieve relief from feelings. Objective: The objective of this paper is to review and evaluate the effectiveness of MBCT on the management of depression. Method: To find appropriate studies,...

Modulation of amygdala reactivity following rapidly acting interventions for major depression.

Human Brain Mapping May 1, 2020 Joana R Loureiro, Amber M Leaver, Megha M Vasavada et al. 65 citations

Electroconvulsive therapy (ECT) and ketamine treatment both induce rapidly acting antidepressant effects in patients with major depressive disorder unresponsive to standard treatments, yet their specific impact on emotion processing is unknown. Here, we examined the neural underpinnings of emotion processing within and across patients (N = 44) receiving either ECT (N = 17, mean age: 36.8, 11.0...

Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy

Medical Science Monitor April 27, 2020 Jie Wang, Yajun Wang, Xudong Xu et al. 80 citations

Background This study investigated the effects of various doses of S-ketamine on depression and pain management of cervical carcinoma patients with mild/moderate depression. Material/Methods This randomized, double-blind, controlled study included 417 cervical carcinoma patients who received laparoscopic modified radical hysterectomy from April 2015 to July 2018 and who also had mild/moderate...

Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder

Journal of Clinical Psychopharmacology April 25, 2020 Marlene P. Freeman, Rebecca S. Hock, George I. Papakostas et al. 45 citations

PURPOSE/BACKGROUND: Major depressive disorder (MDD) and obesity commonly co-occur. We sought to assess the impact of body mass index (BMI) on the acute antidepressant effects of ketamine in patients with treatment-resistant depression. METHODS/PROCEDURES: Post hoc analyses were conducted from a multisite, randomized, double-blind, placebo-controlled trial designed to assess the rapid-onset...

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

The Journal of Clinical Psychiatry April 20, 2020 Ewa Wajs, Leah Aluisio, Richard Holder et al. 288 citations

OBJECTIVE: To evaluate long-term safety and efficacy of esketamine nasal spray plus a new oral antidepressant (OAD) in patients with treatment-resistant depression (TRD). METHODS: This phase 3, open-label, multicenter, long-term (up to 1 year) study was conducted between October 2015 and October 2017. Patients (≥ 18 years) with TRD (DSM-5 diagnosis of major depressive disorder and nonresponse...

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

Pharmacological Reports April 16, 2020 J. Kryst, Paweł Kawalec, Alicja Mikrut Mitoraj et al. 157 citations

Due to unmet clinical needs for efficient drugs with a rapid onset of antidepressant effects, we aimed to evaluate the efficacy of single-dose ketamine in different subgroups of patients with major depression and establish whether repeated ketamine administration could be a viable strategy to maintain treatment gains. Electronic databases (Medline via PubMed, Embase, Cochrane Library, Trip...

The interplay between mindfulness, depression, stress and academic performance in medical students: A Saudi perspective.

PLoS One April 3, 2020 Ahmed M Alzahrani, Ahmed Hakami, Ahmad Alhadi et al.

There is a growing body of research that shows a significant association between mindfulness and mental health. However, studies on Saudi populations are still in their infancy. Mindfulness is a personal tendency to focus on the present time in a non-judgmental manner, including the interior and exterior experience of feelings and events. The first aim of this study is to examine the...